Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors

NCT05037149 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
50
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sirnaomics